stars 1 stars 2 stars 3

MIAC is an imaging CRO supporting international trials with advanced imaging and medical expertise. Originally founded as an academic corporation of the Basel University Hospital in 1995, MIAC today is a company tightly embedded in national and international research networks, driving the translation of novel imaging and post-processing modalities from their development to applications in clinical trials. MIAC is dedicated to advanced imaging, creating high impact scientific outcomes for your international trial, providing our expertise and commitment for personalized customer service. Tailor-made data analysis pipelines in Swiss quality standards ensure custom metrics and transparent gapless data safety for your imaging study. A highly specialized team of board-certified neuro-/radiologists, physicists, biomedical engineers, IT specialists, technicians and clinicians deliver tailor-made image data analysis services and international trial support to the leaders of the pharmaceutical industry. All MIAC services follow the high standards of Swiss quality and comply with the requirements of FDA – 21 CFR Part 11 & ICH – Good Clinical Practices.

MIAC AG Questions

Jens Wuerfel is the CEO of MIAC AG.

9 people are employed at MIAC AG.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users